LISATA THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 1968790, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2015-03-31) |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/03cfa3bd-e3da-482c-b016-c8644f374795
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-15-000028 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/accounts-receivable/2015-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/03cfa3bd-e3da-482c-b016-c8644f374795
History
- no predecessors — first report